LifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc's Board of Trustees as Non-Executive Directors.
How LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease
June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Disease) and to stand in solidarity with the MND/ALS community.
New programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials
LifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
£150,000 grant will fund a study of a biomarker test that could improve outcomes for patients with a rare sarcoma cancer.
LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.
Meet our industrial placement students – class of 2023
Find out what this year's cohort of industrial placement students gained from the experience.
LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
Translational research into children’s rare diseases enters 5th year of collaborative funding
Accelerating research that will have a significant impact on the treatment of children and young people
Dr Jason Slingsby joins LifeArc as Chief Business Officer
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.